首頁 > 市場調查報告書 > 製藥

製藥企業製藥企業資料製藥企業策略

市場調查報告書

商品編碼

2136478

2021-2026年全球學術與非營利夥伴關係及協議條款與條件

Global Academic and Non-Profit Partnering Terms and Agreements 2021-2026

出版日期: 2026年10月01日 | 出版商:

Current Partnering | 英文 1400+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

利用基於 2,448 個真實案例的合約數據，了解製藥和生物技術公司如何與大學、研究機構和非營利組織合作。

《2021-2026 年學術和非營利合作條款及協議》提供了有關 2,448 項夥伴關係涉及製藥和生物技術公司、大學、學術研究機構和非營利組織。

學術機構和非營利組織在生命科學創新中發揮著至關重要的作用，透過與產業界的合作，產生新的科學、技術、療法和智慧財產權。

這些合作關係形式多元。它們可以從初步研究和評估開始，發展成為贊助研究和技術使用協議，或最終達成許可、共同開發和商業化夥伴關係。

本報告將學術機構和非營利組織之間的合作活動進行了全面的概述，彙編成一份文件，使用戶能夠了解「誰在合作」、「哪些組織最活躍」、「正在簽署哪些類型的協議」、「哪些技術和治療領域引起了關注」以及「正在披露哪些財務和合約條款」。

本報告並未著重分析具體的交易模式，而是對各公司在藥物觀點、開發和商業化的各個階段如何與學術機構和非營利組織進行跨產業分析。

本報告為負責人提供實用資訊和基準資料，包括業務發展、授權、外部創新、技術轉移、研究和評估、研發策略、公司策略和法律團隊。

了解產業如何與學術機構和非營利組織合作。

本報告分析了2021年至2026年與學術機構和非營利組織的合作關係，內容包括：

合作活動的年度趨勢
學術機構和非營利組織中最活躍的交易商。
最活躍的產業夥伴
按交易類型分類的合夥活動
按治療區域
技術類型
發展階段
基於已揭露金額的主要合作關係
財務狀況（如公開資訊）
產學合作活動的趨勢
本報告全面觀點了市場狀況，重點介紹了製藥和生物技術公司利用學術研究和外部創新所採用的各種方法。
比較所有類型的合夥結構。
產學合作可以採取多種形式，這取決於所涉及的科學技術的成熟度、參與各方的目標以及未來的商業性機會。

本報告涵蓋多種合作類型，使用者可考慮以下方法：

研究夥伴關係
委託研究
授權協議
科技應用
期權協議和評估協議
共同開發
商業化夥伴關係
製造和供應安排
其他多組分夥伴關係結構
這樣一來，使用者可以比較獲取學術創新成果的不同途徑，而無需單獨考慮許可和研究合作關係。
確定主要大學、研究機構和產業合作夥伴。
本報告列出了與學術機構和非營利組織合作最活躍的組織，並提供了詳細的交易歷史記錄，以便用戶可以調查其過去的活動。

這有助於用戶識別以下內容：

正在與產業界積極合作計畫的大學和研究機構
參與生命科學領域創新的非營利組織
積極吸收學術領域創新成果的製藥和生技公司。
我們在特定技術或治療領域反覆合作的組織。
學術技術和資產的潛在產業合作夥伴
尋求外部創新的公司的潛在學術合作夥伴
過去的活動記錄可以提供有價值的線索，幫助我們了解哪些組織展現了合作意願，以及哪些類型的機會吸引了它們的興趣。
找出學術界創新吸引產業界關注的領域。
本報告分析了學術機構與非營利組織之間的合作關係，並按治療領域、技術類型和發展階段進行分類。

這允許用戶調查以下內容：

在哪些治療領域，學術界和產業界正在進行積極的合作？
吸引外部創新關注的技術
發展階段，在此階段，企業與學術研究進行合作
不同技術和治療領域的合作方式有何不同？
在特定領域反覆運作的組織
對於負責外部創新和探索的團隊來說，這可以提供有價值的背景信息，了解行業興趣正在成長的領域以及哪些組織正在參與其中。
與學術機構和非營利組織合作，對標財務狀況
與學術機構的合作關係在財務結構上差異很大，這取決於研究的性質、智慧財產權、授予的權利以及發展潛力。

本報告對已揭露的財務狀況進行瞭如下分析：

合約總金額
預付款
里程碑付款
版稅率
透過研究這些基準背後的具體合約，使用者可以了解所揭露的經濟狀況的結構和背景。
這為評估和準備學術合作關係提供了一個實用且現實的參考點。
財務基準不應被視為孤立的平均值，而應結合所授予的權利、開發階段以及類似協議的結構來考慮。本報告提供了建立這種背景所需的基礎交易資訊。
了解學術合作中的權利和責任分配。
學術界和非營利組織的協議通常包含有關知識產權、研究責任、出版權和未來商業化的詳細條款。

根據交易性質和披露的信息，用戶可以調查以下方面：

調查責任
研究津貼
智慧財產權所有權
授權和選擇權
獨家版權
與調查相關的權利
專利申請及維護
發展責任
商業化權利
里程碑和版稅
出版權
管治
合約期限和終止條款
這些例子為在產業界和科研機構之間建立新的合作關係提供了寶貴的見解。
從與學術機構和非營利組織的實際合約中學習
本報告提供了公開可取得的與所選夥伴關係相關的基礎合約文件的途徑。

這些協議提供了僅憑新聞稿無法獲得的詳細信息，使用戶能夠了解公司和研究機構如何記錄以下內容：

智慧財產權所有權和許可
調查範圍和責任
資金
選擇權和商業化權利
獨家版權
里程碑達成條件
特許權使用費規定
資訊揭露與保密
管治
合約終止及後續權利
對於業務發展、技術轉移和法律團隊而言，取得實際合約措辭可以提供寶貴的見解，了解類似的產學合作是如何實際建立的。
學術和非營利組織的綜合合約目錄
本報告包含一份全面的目錄，收錄了與學術機構和非營利組織簽訂的 2,448 項合作協議，為識別相關領先和組織提供了廣泛的資訊來源。

交易調查可依據以下標準進行：

公司或組織
發展階段
交易類型
治療區域
技術類型
交易金額
合約資訊揭露狀況
每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
誰該使用這份報告？
業務拓展與授權團隊
尋找學術領域的創新機會、類似協議以及具有相關合作經驗的組織。
外部創新與研究評估團隊
確定在具有策略意義的技術和治療領域開展工作的大學、研究機構和非營利組織。
技術轉移和學術許可團隊
我們將了解其他組織如何與產業合作，確定潛在的商業夥伴，並對類似的協議進行基準比較。
製藥和生物技術公司
我們將了解同一領域的其他公司如何獲得學術研究成果，並找出在相關領域特別活躍的機構。
大學、研究機構、非營利組織
我們尋找對學術創新有明確興趣的公司，並調查與類似技術和資產相關的過往交易記錄。
企業及研發策略團隊
我們將了解學術合作如何促進外部創新和人才培養策略。
法律及交易團隊
我們將仔細審查公開的契約，這些契約規定了知識產權、調查責任、許可、選擇權、財務條款和其他可協商事項。
我們將整個市場中的學術合作關係資訊轉化為針對特定組織的洞察。
符合資格的客戶將收到 Current Partnering 的報告，以及為高階主管量身訂製的合作關係簡報。
本次簡報將說明我們與相關學術機構和非營利組織的合作關係，並將它們與貴方的具體研究領域、技術、資產或策略目標相匹配。
如有需要，我們可以提供相關的領先協議、潛在的學術和行業合作夥伴、活躍的組織、技術和治療領域的分析、財務基準、合約見解以及其他專門為您情況選擇的資訊。
請索取樣本或聯絡 Current Partnering 討論本報告的內容以及我們是否可以為貴組織提供客製化分析。

多年來學術機構與非營利組織合作的發展趨勢
最活躍的學術機構和非營利組織都是貿易夥伴。
按交易類型分類的學術機構與非營利組織之間的合作關係
學術機構與非營利組織在特定治療領域合作
按技術類型分類的學術機構與非營利組織之間的合作關係
學術機構與非營利組織合作的合約條款
- 與學術機構和非營利組織合作中的重大交易金額
- 與學術機構和非營利組織合作的預付款
- 與學術機構和非營利組織合作的里程碑付款
- 與學術機構和非營利組織的版稅率

第3章：與代表性學術機構和非營利組織簽訂的合約範例

按交易量排名的前列學術機構和非營利組織

第4章：學術界和非營利部門最活躍的交易商

學術界和非營利組織中最活躍的交易商
最活躍的學術和非營利合作夥伴公司簡介

第5章：學術界和非營利領域合約交易指南

第6章：不同技術領域學術機構與非營利組織的交易活動

附錄

附錄 1 - 按公司名稱（A-Z）列出的學術和非營利交易
附錄 2 - 按發展階段分類的學術和非營利交易
附錄 3 - 按交易類型分類的學術和非營利交易
附錄 4 - 按治療領域分類的學術和非營利交易
附錄5 - 交易類型的定義
附錄 6 - 參考文獻
關於生物製藥研究
Current Partnering
Current Agreements
理想合作夥伴近期報告標題

簡介目錄

Product Code: CP1011

Academic and Non-Profit Partnering Terms and Agreements 2021-2026

Understand how pharmaceutical and biotechnology companies partner with universities, research institutes and non-profit organizations using intelligence from 2,448 real-world agreements.

Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides comprehensive intelligence on 2,448 partnerships involving pharmaceutical and biotechnology companies, universities, academic research institutions and non-profit organizations.

Academic and non-profit organizations play a fundamental role in life sciences innovation, generating new science, technologies, therapeutic approaches and intellectual property that can progress through collaboration with industry.

These relationships take many forms. They can begin with early research or evaluation, develop into sponsored research or technology access agreements, or lead to licensing, co-development and commercialization partnerships.

This report brings the full spectrum of academic and non-profit partnering activity together in one resource, enabling users to understand who is partnering, which organizations are most active, what types of agreements are being used, which technologies and therapeutic areas are attracting activity, and what financial and contractual terms have been disclosed.

Rather than focusing on a single deal type, the report provides a cross-industry view of how companies engage with academic and non-profit innovation across discovery, development and commercialization.

It provides a practical intelligence and benchmarking resource for business development, licensing, external innovation, technology transfer, search and evaluation, R&D strategy, corporate strategy and legal teams involved in academic-industry partnering.

Understand how industry partners with academia and non-profit organizations

The report analyzes academic and non-profit partnering from 2021 to 2026, including:

Trends in partnering activity by year
Most active academic and non-profit dealmakers
Most active industry partners
Partnering activity by deal type
Therapy area
Technology type
Stage of development
Leading partnerships by disclosed value
Financial terms where available
How academic-industry partnering activity is evolving
This provides a market-wide view of the different ways pharmaceutical and biotechnology companies are accessing academic research and external innovation.
Compare the full range of partnership structures
Academic-industry relationships can be structured very differently depending on the maturity of the science, objectives of the parties and future commercial opportunity.

The report spans multiple partnership types, enabling users to investigate approaches including:

Research collaborations
Sponsored research
Licensing agreements
Technology access
Option and evaluation agreements
Development collaborations
Commercialization partnerships
Manufacturing and supply arrangements
Other multi-component partnering structures
This enables users to compare different routes for accessing academic innovation rather than looking at licensing or research collaboration in isolation.
Identify leading universities, research institutions and industry partners
The report identifies the most active organizations in academic and non-profit partnering and provides detailed transaction histories that enable users to investigate their previous activity.

This can help users identify:

Universities and research institutions with active industry partnering programs
Non-profit organizations involved in life sciences innovation
Pharmaceutical and biotechnology companies actively sourcing academic innovation
Organizations repeatedly partnering in particular technologies or therapeutic areas
Potential industry partners for academic technologies and assets
Potential academic collaborators for companies seeking external innovation
Historical activity can provide valuable evidence of which organizations have demonstrated a willingness to work together and the types of opportunities that attract their interest.
Understand where academic innovation is attracting industry interest
The report analyzes academic and non-profit partnering by therapy area, technology type and stage of development.

This enables users to investigate:

Which therapeutic areas are generating significant academic-industry activity
Technologies attracting external innovation interest
The development stages at which companies engage with academic research
How partnering approaches differ across technologies and therapeutic fields
Organizations repeatedly active in particular areas
For external innovation and search teams, this can provide valuable context around where industry interest is developing and which organizations are participating.
Benchmark academic and non-profit deal financials
Academic partnerships vary substantially in financial structure according to the nature of the research, intellectual property, rights granted and development potential.

The report provides analysis of disclosed financial terms, including:

Headline deal values
Upfront payments
Milestone payments
Royalty rates
Users can investigate the individual agreements behind these benchmarks to understand the structure and circumstances surrounding the disclosed economics.
This provides useful real-world reference points when evaluating or preparing academic partnerships.
Financial benchmarks should be considered alongside the rights granted, development stage and structure of comparable agreements rather than as standalone averages, and the report provides the underlying transaction intelligence needed to establish that context.
Understand how academic partnerships allocate rights and responsibilities
Academic and non-profit agreements frequently involve detailed provisions concerning intellectual property, research responsibility, publication rights and future commercialization.

Depending on the transaction and available disclosure, users can investigate areas including:

Research responsibilities
Sponsored research funding
Intellectual property ownership
Licensing and option rights
Exclusivity
Rights to research results
Patent prosecution and maintenance
Development responsibilities
Commercialization rights
Milestones and royalties
Publication rights
Governance
Term and termination provisions
These real-world examples provide useful reference points when structuring new relationships between industry and research institutions.
Learn from real-world academic and non-profit contracts
Where publicly available, the report provides access to underlying contract documents for selected partnerships.

These agreements can provide substantially more detail than press releases alone, allowing users to examine how companies and research institutions have documented matters including:

Intellectual property ownership and licensing
Research scope and responsibilities
Funding
Option and commercialization rights
Exclusivity
Milestone triggers
Royalty provisions
Publication and confidentiality
Governance
Termination and continuing rights
For business development, technology transfer and legal teams, access to real agreement language provides valuable insight into how comparable academic-industry partnerships have been structured in practice.
Comprehensive academic and non-profit deal directory
The report includes a comprehensive directory of 2,448 academic and non-profit partnering agreements, providing an extensive resource for identifying relevant precedent transactions and organizations.

Deals can be investigated by:

Company or institution
Stage of development
Deal type
Therapy area
Technology type
Deal value
Contract availability
Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
Who should use this report?
Business Development and Licensing teams
Identify academic innovation opportunities, comparable agreements and organizations with relevant partnering experience.
External Innovation and Search & Evaluation teams
Identify universities, research institutes and non-profits active in technologies and therapeutic areas of strategic interest.
Technology Transfer and Academic Licensing teams
Understand how other institutions are partnering with industry, identify potential commercial partners and benchmark comparable agreements.
Pharmaceutical and Biotechnology Companies
Understand how peer companies access academic research and which institutions are particularly active in relevant areas.
Universities, Research Institutes and Non-Profit Organizations
Identify companies with demonstrated interest in academic innovation and investigate precedent transactions involving comparable technologies and assets.
Corporate and R&D Strategy teams
Understand how academic collaboration contributes to external innovation and pipeline development strategies.
Legal and Transaction teams
Review publicly available agreements covering intellectual property, research responsibilities, licensing, option rights, financial terms and other negotiated provisions.
Turn market-wide academic partnering intelligence into organization-specific insight
For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
The briefing applies the underlying academic and non-profit partnering intelligence to the customer's own research interests, technologies, assets or strategic objectives.
Depending on requirements, this can include relevant precedent agreements, prospective academic or industry partners, active institutions, technology and therapy-area analysis, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Academic and Non-Profit dealmaking

2.1. Introduction
2.2. Academic and Non-Profit partnering over the years
2.3. Most active Academic and Non-Profit dealmakers
2.4. Academic and Non-Profit partnering by deal type
2.5. Academic and Non-Profit partnering by therapy area
2.6. Academic and Non-Profit partnering by technology type
2.7. Deal terms for Academic and Non-Profit partnering
- 2.7.1 Academic and Non-Profit partnering headline values
- 2.7.2 Academic and Non-Profit deal upfront payments
- 2.7.3 Academic and Non-Profit deal milestone payments
- 2.7.4 Academic and Non-Profit royalty rates